Who owns Champions Oncology?

Tip: Access positions for across all investors

Analyze quarterly positions in Champions Oncology with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Champions Oncology stock

Who bought or sold Champions Oncology this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Battery Management Corp. 2.4M $12M 0% Sep 2024
 View chart
NEA Management Company 1.7M $8.3M 0% Sep 2024
 View chart
Tocqueville Asset Management 705k $3.4M 3% Sep 2024
 View chart
Vanguard Group 307k $1.6M 259% Jun 2024
 View chart
Renaissance Technologies 120k $584k -2% Sep 2024
 View chart
BlackRock 116k $566k 100% Sep 2024
 View chart
BlackRock 116k $600k 0% Jun 2024
 View chart
Goldman Sachs Group 69k $358k 0% Jun 2024
 View chart
Geode Capital Management 65k $317k 3% Sep 2024
 View chart
Morgan Stanley 43k $223k 6% Jun 2024
 View chart
Northern Trust 41k $200k -4% Sep 2024
 View chart
HighTower Advisors 34k $178k 0% Jun 2024
 View chart
Acadian Asset Management 31k $148k 0% Sep 2024
 View chart
Bank of New York Mellon 27k $130k 0% Sep 2024
 View chart
State Street Corporation 27k $137k 0% Jun 2024
 View chart
Bank of America Corporation 25k $123k 0% Sep 2024
 View chart
Susquehanna International 15k $73k 100% Sep 2024
 View chart
Cambridge Investment Research Advisors 12k $60k 0% Sep 2024
 View chart
Mesirow Financial Investment Management International Equity 12k $58k 0% Sep 2024
 View chart
Stifel Financial 11k $57k -2% Jun 2024
 View chart
Simplex Trading 113.00 $0 -96% Sep 2024
 View chart
Jpmorgan Chase & Co 11.00 $54.000100 0% Sep 2024
 View chart

Who sold out of Champions Oncology?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Jun 2024 20k $101k
Royal Bank of Canada Jun 2024 133.00 $1.0k